Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Equity (2020 - 2025)

Mirum Pharmaceuticals (MIRM) has 6 years of Return on Equity data on record, last reported at 0.08% in Q4 2025.

  • For Q4 2025, Return on Equity rose 31.0% year-over-year to 0.08%; the TTM value through Dec 2025 reached 0.08%, up 31.0%, while the annual FY2025 figure was 0.09%, 28.0% up from the prior year.
  • Return on Equity reached 0.08% in Q4 2025 per MIRM's latest filing, up from 0.15% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.08% in Q4 2025 and bottomed at 2.35% in Q3 2021.
  • Average Return on Equity over 5 years is 0.73%, with a median of 0.62% recorded in 2022.
  • Peak YoY movement for Return on Equity: surged 205bps in 2022, then crashed -112bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.95% in 2021, then grew by 9bps to 0.87% in 2022, then rose by 28bps to 0.63% in 2023, then skyrocketed by 39bps to 0.38% in 2024, then skyrocketed by 80bps to 0.08% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.08% in Q4 2025, 0.15% in Q3 2025, and 0.24% in Q2 2025.